Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 572

The DOI matches its Crossref record.

RISKS OF INTRAVITREOUS INJECTION: A COMPREHENSIVE REVIEW

JAGER, RAMA D., AIELLO, LLOYD PAUL, PATEL, SAMIR C., CUNNINGHAM, EMMETT T.·2004·Retina
DOI 10.1097/00006982-200410000-00002
Open this paper in CoChat — free account

Abstract

In Brief Purpose: To evaluate the prevalence of the most common serious adverse events associated with intravitreous (IVT) injection. Methods: A systematic search of the literature via PubMed from 1966 to March 1, 2004, was conducted to identify studies evaluating the safety of IVT injection. Data submitted in New Drug Applications to the U.S. Food and Drug Administration for drugs administered into the vitreous were included where available. Serious adverse events reported in each study were recorded, and risk per eye and risk per injection were calculated for the following serious adverse events: endophthalmitis, retinal detachment, iritis/uveitis, intraocular hemorrhage, ocular hypertension, cataract, and hypotony. Rare complications also were noted. Results: Data from 14,866 IVT injections in 4,382 eyes were analyzed. There were 38 cases of endophthalmitis (including those reported as pseudoendophthalmitis) for a prevalence of 0.3% per injection and 0.9% per eye. Excluding cases reported specifically as pseudoendophthalmitis, the prevalence of endophthalmitis was 0.2% per injection and 0.5% per eye. Retinal detachment, iritis/uveitis, ocular hypertension, cataract, intraocular hemorrhage, and hypotony were generally associated with IVT injection of specific compounds and were infrequently attributed by the investigators to the injection procedure itself. Retinal vascular occlusions were described rarely in patients after IVT injection, and it was unclear in most cases whether these represented true injection-related complications or chance associations. Conclusion: The risk of serious adverse events reported after IVT injection is low. Nevertheless, careful attention to injection technique and appropriate postinjection monitoring are essential because uncommon injection-related complications may be associated with permanent vision loss. Adverse event data from 14,866 intravitreous injections reported in the literature were used to calculate the risk of endophthalmitis, retinal detachment, iritis/uveitis, intraocular hemorrhage, ocular hypertension, cataract, and hypotony. While the risks associated with IVT injection appear to be quite low, serious complications associated with vision loss may occur following IVT injection.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00006982-200410000-00002

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 104

  1. Baudouin, 1996, Ophthalmologica, 210, 329, 10.1159/000310734 · DOI
  2. Cochereau-Massin, 1991, Ophthalmology, 98, 1348, 10.1016/S0161-6420(91)32135-3 · doi:10.1016/s0161-6420(91)32135-3
  3. Hodge, 1996, J Infect Dis, 174, 393, 10.1093/infdis/174.2.393 · DOI
  4. Kirsch, 1995, Ophthalmology, 102, 533, 10.1016/S0161-6420(95)30985-2 · doi:10.1016/s0161-6420(95)30985-2
  5. Rahhal, 1996, Ophthalmology, 103, 1078, 10.1016/S0161-6420(96)30564-2 · DOI
  6. Taskintuna, 1997, Ophthalmology, 104, 1049, 10.1016/S0161-6420(97)30188-2 · DOI
  7. Taskintuna, 1997, Ophthalmology, 104, 1827, 10.1016/S0161-6420(97)30020-7 · doi:10.1016/s0161-6420(97)30020-7
  8. 2002, Am J Ophthalmol, 133, 484, 10.1016/S0002-9394(02)01332-6 · DOI
  9. 2002, Am J Ophthalmol, 133, 475, 10.1016/S0002-9394(02)01326-0 · DOI
  10. Young, 1998, Ophthalmology, 105, 1404, 10.1016/S0161-6420(98)98020-4 · DOI
  11. Young, 1992, Med J Aust, 157, 370, 10.5694/j.1326-5377.1992.tb137242.x · DOI
  12. Hilton, 1987, Ophthalmology, 94, 307, 10.1016/S0161-6420(87)33446-3 · doi:10.1016/s0161-6420(87)33446-3
  13. Sebag, 1993, Retina, 13, 8, 10.1097/00006982-199313010-00003 · doi:10.1097/00006982-199313010-00003
  14. Tornambe, 1989, Ophthalmology, 96, 772, 10.1016/S0161-6420(89)32820-X · DOI · Paper page
  15. Hattenbach, 2001, Ophthalmology, 108, 1485, 10.1016/S0161-6420(01)00648-0 · DOI · Paper page
  16. Lahey, 1999, Ophthalmic Surg Lasers, 30, 427, 10.3928/1542-8877-19990601-04 · doi:10.3928/1542-8877-19990601-04
  17. Doft, 1998, Ophthalmology, 105, 707, 10.1016/S0161-6420(98)94028-3 · doi:10.1016/s0161-6420(98)94028-3
  18. Liu, 2000, J Infect Dis, 182, 1234, 10.1086/315851 · doi:10.1086/315851
  19. Smith, 1998, Arch Ophthalmol, 116, 178
  20. Knox, 1998, Ophthalmology, 105, 37, 10.1016/S0161-6420(98)71127-2 · doi:10.1016/s0161-6420(98)71127-2
  21. Ganatra, 2000, Am J Ophthalmol, 129, 166, 10.1016/S0002-9394(99)00316-5 · doi:10.1016/s0002-9394(99)00316-5
  22. Bodaghi, 2002, Ophthalmol Clin North Am, 15, 271, 10.1016/S0896-1549(02)00037-8 · doi:10.1016/s0896-1549(02)00037-8
  23. Grigg, 2001, J Infect Dis, 184, 633, 10.1086/322800 · DOI · Paper page
  24. 2002, Retina, 22, 143, 10.1097/00006982-200204000-00002 · DOI · Paper page
  25. 2003, Ophthalmology, 110, 979, 10.1016/S0161-6420(03)00085-X · DOI · Paper page
  26. Chang, 2004, Invest Ophthalmol Vis Sci, 45, E, 10.1167/iovs.03-1113 · DOI
  27. Heier, 2003, Invest Ophthalmol Vis Sci, &NA;, 44
  28. Bakri, 2003, Ophthalmic Surg Lasers Imaging, 34, 386, 10.3928/1542-8877-20030901-08 · DOI · Paper page
  29. Jonas, 2003, Arch Ophthalmol, 121, 57, 10.1001/archopht.121.1.57 · DOI · Paper page
  30. Danis, 2000, Retina, 20, 244, 10.1097/00006982-200003000-00004 · DOI · Paper page
  31. Jonas, 2003, Br J Ophthalmol, 87, 462, 10.1136/bjo.87.4.462 · DOI · Paper page
  32. Gillies, 2003, Arch Ophthalmol, 121, 667, 10.1001/archopht.121.5.667 · DOI · Paper page
  33. Penfold, 1995, Aust N Z J Ophthalmol, 23, 293, 10.1111/j.1442-9071.1995.tb00179.x · DOI · Paper page
  34. Ohm, 1911, Albrecht von Graefes Arch Ophthalmol, 79, 442, 10.1007/BF01977971 · DOI
  35. Schneider, 1947, Arch Ophthalmol, 37, 304, 10.1001/archopht.1947.00890220314006 · DOI
  36. Rycroft, 1945, Br J Ophthalmol, 29, 57, 10.1136/bjo.29.2.57 · DOI
  37. Rosengren, 1952, Acta Ophthalmol (Copenh), 30, 117
  38. Cibis, 1962, Arch Ophthalmol, 68, 590, 10.1001/archopht.1962.00960030594005 · doi:10.1001/archopht.1962.00960030594005
  39. Forster, 1976, Am J Ophthalmol, 81, 52, 10.1016/0002-9394(76)90190-2 · doi:10.1016/0002-9394(76)90190-2
  40. Peyman, 1978, Ophthalmology, 85, 374, 10.1016/S0161-6420(78)35659-1 · doi:10.1016/s0161-6420(78)35659-1
  41. Blumenkranz, 1984, Ophthalmology, 91, 122, 10.1016/S0161-6420(84)34318-4 · DOI · Paper page
  42. Henry, 1987, Am J Ophthalmol, 103, 17, 10.1016/S0002-9394(14)74163-7 · DOI · Paper page
  43. Blankenship, 1991, Graefes Arch Clin Exp Ophthalmol, 229, 62, 10.1007/BF00172263 · doi:10.1007/bf00172263
  44. Fishburne, 1997, Arch Ophthalmol, 115, 1152, 10.1001/archopht.1997.01100160322009 · DOI · Paper page
  45. Hassan, 1999, Ophthalmology, 106, 1900, 10.1016/S0161-6420(99)90399-8 · DOI · Paper page
  46. Peyman, 1974, Can J Ophthalmol, 9, 322
  47. Peyman, 1975, Ophthalmic Surg, 6, 45
  48. Baum, 1978, Ophthalmology, 85, 350, 10.1016/S0161-6420(78)35665-7 · doi:10.1016/s0161-6420(78)35665-7
  49. Barza, 1980, Invest Ophthalmol Vis Sci, 19, 1348
  50. McCuen, 1981, Am J Ophthalmol, 91, 785, 10.1016/0002-9394(81)90013-1 · DOI · Paper page
  51. Tano, 1980, Am J Ophthalmol, 90, 810, 10.1016/S0002-9394(14)75196-7 · DOI · Paper page
  52. Hauswirth, 2004, Novartis Found Symp, 255, 179, 10.1002/0470092645.ch14 · DOI
  53. Coco, 1998, J Ocul Pharmacol Ther, 14, 555, 10.1089/jop.1998.14.555 · DOI
  54. Wingard, 1989, Invest Ophthalmol Vis Sci, 30, 2184
  55. Schindler, 1982, Am J Ophthalmol, 93, 415, 10.1016/0002-9394(82)90130-1 · DOI · Paper page
  56. Stay, 2003, Pharm Res, 20, 96, 10.1023/A:1022207026982 · DOI
  57. Mordenti, 1999, Toxicol Pathol, 27, 536, 10.1177/019262339902700507 · DOI · Paper page
  58. Scholes, 1985, Arch Ophthalmol, 103, 1567, 10.1001/archopht.1985.01050100143037 · DOI
  59. Jonas, 2002, Br J Ophthalmol, 86, 1066, 10.1136/bjo.86.9.1066 · doi:10.1136/bjo.86.9.1066
  60. Beer, 2003, Ophthalmology, 110, 681, 10.1016/S0161-6420(02)01969-3 · DOI · Paper page
  61. Moldow, 1999, Invest Ophthalmol Vis Sci, 40, 1770
  62. Drolet, 2000, Pharm Res, 17, 1503, 10.1023/A:1007657109012 · DOI · Paper page
  63. Sebag, 1987, Graefes Arch Clin Exp Ophthalmol, 225, 89, 10.1007/BF02160337 · DOI · Paper page
  64. Moshfeghi, 2003, Am J Ophthalmol, 136, 791, 10.1016/S0002-9394(03)00483-5 · DOI · Paper page
  65. Nelson, 2003, Retina, 23, 686, 10.1097/00006982-200310000-00014 · DOI · Paper page
  66. Roth, 2003, Arch Ophthalmol, 121, 1279, 10.1001/archopht.121.9.1279 · DOI · Paper page
  67. Friberg, 2001, Ophthalmic Surg Lasers, 32, 13, 10.3928/1542-8877-20010101-04 · doi:10.3928/1542-8877-20010101-04
  68. Friberg, 1988, Ophthalmology, 95, 187, 10.1016/S0161-6420(88)33196-9 · doi:10.1016/s0161-6420(88)33196-9
  69. Smith, 2002, Ophthalmology, 109, 1709, 10.1016/S0161-6420(02)01125-9 · DOI · Paper page
  70. Sutter, 2003, Br J Ophthalmol, 87, 972, 10.1136/bjo.87.8.972 · DOI · Paper page
  71. Eifrig, 2002, Ophthalmic Surg Lasers, 33, 373, 10.3928/1542-8877-20020901-06 · doi:10.3928/1542-8877-20020901-06
  72. 1995, Arch Ophthalmol, 113, 1479, 10.1001/archopht.1995.01100120009001 · DOI · Paper page
  73. Hassan, 1992, J Hosp Infect, 22, 271, 10.1016/0195-6701(92)90012-B · DOI
  74. Olson, 1983, Ophthalmology, 90, 692, 10.1016/S0161-6420(83)34511-5 · doi:10.1016/s0161-6420(83)34511-5
  75. Puliafito, 1982, Ophthalmology, 89, 921, 10.1016/S0161-6420(82)34704-1 · doi:10.1016/s0161-6420(82)34704-1
  76. Sandvig, 2003, J Cataract Refract Surg, 29, 1273, 10.1016/S0886-3350(02)02048-5 · doi:10.1016/s0886-3350(02)02048-5
  77. Shane, 2003, Am J Ophthalmol, 136, 649, 10.1016/S0002-9394(03)00333-7 · DOI
  78. Shrader, 1990, J Infect Dis, 162, 115, 10.1093/infdis/162.1.115 · doi:10.1093/infdis/162.1.115
  79. Somani, 1997, Can J Ophthalmol, 32, 303
  80. Wong, 2004, Ophthalmology, 111, 699, 10.1016/j.ophtha.2003.07.014 · doi:10.1016/j.ophtha.2003.07.014
  81. Aaberg, 1998, Ophthalmology, 105, 1004, 10.1016/S0161-6420(98)96000-6 · DOI · Paper page
  82. Semmens, 2003, Clin Exp Ophthalmol, 31, 213, 10.1046/j.1442-9071.2003.00647.x · doi:10.1046/j.1442-9071.2003.00647.x
  83. Montan, 1998, Ophthalmology, 105, 2171, 10.1016/S0161-6420(98)91211-8 · DOI
  84. Kresloff, 1998, Surv Ophthalmol, 43, 193, 10.1016/S0039-6257(98)00036-8 · DOI · Paper page
  85. Speaker, 1991, Ophthalmology, 98, 639, 10.1016/S0161-6420(91)32239-5 · DOI · Paper page
  86. Bannerman, 1997, Arch Ophthalmol, 115, 357, 10.1001/archopht.1997.01100150359008 · doi:10.1001/archopht.1997.01100150359008
  87. Ta, 2004, Retina, 24, 699, 10.1097/00006982-200410000-00003 · DOI
  88. Bartz-Schmidt, 1996, Graefes Arch Clin Exp Ophthalmol, 234, S51, 10.1007/BF02343048 · doi:10.1007/bf02343048
  89. Bohigian, 1986, Am J Ophthalmol, 101, 332, 10.1016/0002-9394(86)90829-9 · doi:10.1016/0002-9394(86)90829-9
  90. Sarrafizadeh, 2001, Ophthalmology, 108, 2273, 10.1016/S0161-6420(01)00822-3 · doi:10.1016/s0161-6420(01)00822-3
  91. Davis, 1997, Arch Ophthalmol, 115, 733, 10.1001/archopht.1997.01100150735008 · doi:10.1001/archopht.1997.01100150735008
  92. Robinson, 2000, Am J Ophthalmol, 130, 49, 10.1016/S0002-9394(00)00530-4 · doi:10.1016/s0002-9394(00)00530-4
  93. Cunningham, 2000, Br J Ophthalmol, 84, 233, 10.1136/bjo.84.3.233 · doi:10.1136/bjo.84.3.233
  94. Carnahan, 2000, Curr Opin Ophthalmol, 11, 478, 10.1097/00055735-200012000-00016 · DOI · Paper page
  95. Gillies, 2004, Arch Ophthalmol, 122, 336, 10.1001/archopht.122.3.336 · DOI · Paper page
  96. Challa, 1998, Aust N Z J Ophthalmol, 26, 277, 10.1111/j.1442-9071.1998.tb01330.x · DOI · Paper page
  97. Tornambe, 1991, Ophthalmology, 98, 1115, 10.1016/S0161-6420(91)32168-7 · DOI
  98. Recchia, 2000, Curr Opin Ophthalmol, 11, 462, 10.1097/00055735-200012000-00013 · DOI
  99. Kraushar, 1994, Retina, 14, 187, 10.1097/00006982-199414020-00015 · doi:10.1097/00006982-199414020-00015
  100. Mo, 2001, Eur J Immunol, 31, 3806, 10.1002/1521-4141(200112)31:12<3806::AID-IMMU3806>3.0.CO;2-M · DOI
  101. Dick, 2003, Eur J Ophthalmol, 13, 176, 10.1177/112067210301300209 · doi:10.1177/112067210301300209
  102. Peters, 2001, J Cataract Refract Surg, 27, 917, 10.1016/S0886-3350(00)00779-3 · doi:10.1016/s0886-3350(00)00779-3
  103. Park, 1997, Korean J Ophthalmol, 11, 51, 10.3341/kjo.1997.11.1.51 · doi:10.3341/kjo.1997.11.1.51
  104. Friedrich, 1997, Curr Eye Res, 16, 663, 10.1076/ceyr.16.7.663.5061 · DOI

Cited by

See all 572

Metadata

Authors
JAGER, R. D., AIELLO, L. P., PATEL, S. C., & CUNNINGHAM, E. T.
Venue
Retina
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2004-10
Volume
24
Issue
5
Pages
676-698
ISSN
0275-004X (ISSN-L)
DOI
10.1097/00006982-200410000-00002
OpenAlex
W2059265707
Cited by
572
References
0
FWCI
22.50
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: RISKS OF INTRAVITREOUS INJECTION: A COMPREHENSIVE REVIEW. https://app.cochat.ai/papers/10.1097/00006982-200410000-00002
The paper
JAGER, R. D., AIELLO, L. P., PATEL, S. C., & CUNNINGHAM, E. T. (2004). RISKS OF INTRAVITREOUS INJECTION: A COMPREHENSIVE REVIEW. Retina. https://doi.org/10.1097/00006982-200410000-00002

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.